Gates Foundation Names Novartis AG Executive To Head Global Health Program

The Bill & Melinda Gates Foundation on Tuesday announced that Trevor Mundel, a senior executive at the pharmaceutical company Novartis AG, will join the foundation on December 1 “as president of the philanthropy’s global health group, a position that can influence the health of millions of people worldwide,” the Wall Street Journal reports (Guth, 9/14). “He succeeds Tadataka ‘Tachi’ Yamada, who left the foundation in June after five years as head of the global health program,” according to the Associated Press/Washington Post (9/13).

“As the program’s president, Mundel will lead the foundation’s efforts in developing and delivering drugs, vaccines and other tools to cope with diseases and illnesses, including initiatives to eradicate polio. He will oversee the organization’s global-health grants, which the foundation says total more than $14.7 billion to date,” the Seattle Times writes (9/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.